Mahajan Imaging & Labs and Fortis La Femme Forge Strategic Alliance to Advance Women’s and Children’s Healthcare

This marks the third partnership between Mahajan Imaging & Labs and the Fortis network, reinforcing a shared commitment to delivering holistic, patient-first healthcare. The alliance not only strengthens access to cutting-edge medical technologies but also sets a new benchmark in integrated care for women and children in India.

Mahajan Imaging & Labs and Fortis La Femme Forge Strategic Alliance to Advance Women’s and Children’s Healthcare
Business

Mahajan Imaging & Labs, a pioneer in advanced medical imaging and integrated diagnostics, has announced a strategic collaboration with Fortis La Femme, India’s leading hospital dedicated to women’s and children’s health. This partnership is set to redefine standards in diagnostics and clinical care, creating a comprehensive healthcare ecosystem for women and children.

The collaboration was marked by the inauguration of the newly upgraded Radiology Department at Fortis La Femme, New Delhi, by veteran actress and Padma Bhushan awardee Sharmila Tagore. The department, established as a Centre of Excellence in High-Resolution Fetal Imaging, combines state-of-the-art technology with patient-centric design, offering a warm, dignified, and comfortable experience while delivering greater precision in maternal and pediatric diagnostics.

Through this alliance, Mahajan Imaging & Labs extends its extensive diagnostic expertise—spanning MRI, CT, PET-CT, Nuclear Medicine, Genomics, Pathology, and Full-Field Digital Mammography—across Delhi-NCR. Families will benefit from seamless access to world-class diagnostics, complemented by Fortis La Femme’s strengths in maternity, gynecology, fertility, pediatrics, neonatology, preventive health, and surgery. Together, the institutions create a 360-degree continuum of care designed to drive early detection, accurate diagnosis, and personalized treatment.

The need for such integrated care is pressing. In Delhi-NCR:

  • Cancer cases among women are projected to surge by 19.3% by 2026, rising from 12,772 in 2021 to 15,244, with breast and cervical cancers being the most prevalent.
  • Gestational Diabetes Mellitus (GDM) affects nearly 14% of women in the region.

By addressing these challenges through advanced diagnostics and preventive screenings, the collaboration seeks to empower women and families with timely, personalized healthcare solutions.

This marks the third partnership between Mahajan Imaging & Labs and the Fortis network, reinforcing a shared commitment to delivering holistic, patient-first healthcare. The alliance not only strengthens access to cutting-edge medical technologies but also sets a new benchmark in integrated care for women and children in India.